Study of Resilience and Loneliness in Youth (18 - 25 Years Old) During the COVID-19 Pandemic Lock-down Measures.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04371250|
Recruitment Status : Active, not recruiting
First Posted : May 1, 2020
Last Update Posted : June 30, 2020
The outbreak linked to SARS-CoV-2 pandemic resulted in lock-down measures in almost all European countries.
This online survey assesses these measures implications on Mental Health in emerging adults.
The questionnaires evaluate two psychometric variables (Resilience and Loneliness) and Mental Health status (mental health professional help-seeking, use of psychotropic drugs, or possible diagnosis) before and during Lock-down Measures.
At least 600 healthy participants aged form 18 to 25 years old will be attended to fill the survey during the SARS-CoV2 Pandemic Lock-down Measures.
|Condition or disease||Intervention/treatment|
|Resilience, Psychological Loneliness Youth Surveys and Questionnaires||Other: Survey and Questionnaire|
|Study Type :||Observational|
|Actual Enrollment :||800 participants|
|Official Title:||Mental Health Implications During and After the COVID-19 Pandemic Lock-down Measures in Youth (18 - 25 Years Old) in French-Speaking Belgium and Italy: Resilience and Loneliness Evaluation.|
|Actual Study Start Date :||April 30, 2020|
|Actual Primary Completion Date :||May 31, 2020|
|Estimated Study Completion Date :||December 30, 2020|
Other: Survey and Questionnaire
Resilience and Loneliness questionnaires
- Self-rated measure of Resilience [ Time Frame: Up to 1 week after the end of the lock-down measures ]Measured with the Resilience Scale for Adults (RSA).
- Self-rated measure of Loneliness [ Time Frame: Up to 1 week after the end of the lock-down measures ]Measured with the UCLA (University of California, Los Angeles) Loneliness Scale.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04371250
|Erasme University Hospital|
|Brussels, Belgium, 1070|